Among the top ten pathways, six were included in all three subsets (i.e., small cell lung cancer, EGFR tyrosine kinase inhibitor resistance, endometrial cancer, PI3K-Akt signaling pathway, endocrine resistance, and cholinergic synapse; as illustrated in Figure 2). This evidence concerns the gene PIK3CA and endometrial cancer.